Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2064253rdf:typepubmed:Citationlld:pubmed
pubmed-article:2064253lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:2064253lifeskim:mentionsumls-concept:C0024440lld:lifeskim
pubmed-article:2064253lifeskim:mentionsumls-concept:C0000981lld:lifeskim
pubmed-article:2064253lifeskim:mentionsumls-concept:C0439851lld:lifeskim
pubmed-article:2064253lifeskim:mentionsumls-concept:C1707520lld:lifeskim
pubmed-article:2064253lifeskim:mentionsumls-concept:C1552596lld:lifeskim
pubmed-article:2064253lifeskim:mentionsumls-concept:C1947931lld:lifeskim
pubmed-article:2064253lifeskim:mentionsumls-concept:C2699488lld:lifeskim
pubmed-article:2064253pubmed:issue4lld:pubmed
pubmed-article:2064253pubmed:dateCreated1991-8-5lld:pubmed
pubmed-article:2064253pubmed:abstractTextWe report the case of a patient with pseudophakic cystoid macular edema whose visual acuity improved promptly with oral administration of 500 mg of acetazolamide extended-release capsules BID for two weeks. However, vision worsened again within two weeks of discontinuation of the treatment. On resumption of acetazolamide therapy for three weeks, and its slow withdrawal during the following three weeks, the macular edema eventually resolved, and vision returned to normal. Our observation provides a direct correlation of the resolution of pseudophakic cystoid macular edema with acetazolamide therapy and shows the importance of tapering the doses of this regimen.lld:pubmed
pubmed-article:2064253pubmed:languageenglld:pubmed
pubmed-article:2064253pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2064253pubmed:citationSubsetIMlld:pubmed
pubmed-article:2064253pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2064253pubmed:statusMEDLINElld:pubmed
pubmed-article:2064253pubmed:monthAprlld:pubmed
pubmed-article:2064253pubmed:issn0003-4886lld:pubmed
pubmed-article:2064253pubmed:authorpubmed-author:TripathiR CRClld:pubmed
pubmed-article:2064253pubmed:authorpubmed-author:ErnestJ TJTlld:pubmed
pubmed-article:2064253pubmed:authorpubmed-author:TripathiB JBJlld:pubmed
pubmed-article:2064253pubmed:authorpubmed-author:FekratSSlld:pubmed
pubmed-article:2064253pubmed:issnTypePrintlld:pubmed
pubmed-article:2064253pubmed:volume23lld:pubmed
pubmed-article:2064253pubmed:ownerNLMlld:pubmed
pubmed-article:2064253pubmed:authorsCompleteYlld:pubmed
pubmed-article:2064253pubmed:pagination127-9lld:pubmed
pubmed-article:2064253pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:2064253pubmed:meshHeadingpubmed-meshheading:2064253-...lld:pubmed
pubmed-article:2064253pubmed:meshHeadingpubmed-meshheading:2064253-...lld:pubmed
pubmed-article:2064253pubmed:meshHeadingpubmed-meshheading:2064253-...lld:pubmed
pubmed-article:2064253pubmed:meshHeadingpubmed-meshheading:2064253-...lld:pubmed
pubmed-article:2064253pubmed:meshHeadingpubmed-meshheading:2064253-...lld:pubmed
pubmed-article:2064253pubmed:meshHeadingpubmed-meshheading:2064253-...lld:pubmed
pubmed-article:2064253pubmed:meshHeadingpubmed-meshheading:2064253-...lld:pubmed
pubmed-article:2064253pubmed:meshHeadingpubmed-meshheading:2064253-...lld:pubmed
pubmed-article:2064253pubmed:meshHeadingpubmed-meshheading:2064253-...lld:pubmed
pubmed-article:2064253pubmed:meshHeadingpubmed-meshheading:2064253-...lld:pubmed
pubmed-article:2064253pubmed:meshHeadingpubmed-meshheading:2064253-...lld:pubmed
pubmed-article:2064253pubmed:year1991lld:pubmed
pubmed-article:2064253pubmed:articleTitleA direct correlation of the resolution of pseudophakic cystoid macular edema with acetazolamide therapy.lld:pubmed
pubmed-article:2064253pubmed:affiliationDepartment of Ophthalmology and Visual Science, University of Chicago, IL 60637.lld:pubmed
pubmed-article:2064253pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2064253pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2064253lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2064253lld:pubmed